You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR CHOLINE C-11

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Choline C-11

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003410 ↗	Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas	Completed	National Cancer Institute (NCI)	Phase 1	1998-07-01	RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma.
NCT00003410 ↗	Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas	Completed	Jonsson Comprehensive Cancer Center	Phase 1	1998-07-01	RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma.
NCT00004697 ↗	Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition	Completed	University of Texas	N/A	1997-11-01	OBJECTIVES: I. Determine whether intravenous choline supplementation will reverse the hepatic steatosis and improve liver function in patients who receive long term total parenteral nutrition.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Choline C-11

Condition Name

Chart
Table

Condition Name for Choline C-11
Intervention	Trials
Prostate Cancer	19
Prader-Willi Syndrome	6
Dyslipidemia	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Choline C-11
Intervention	Trials
Prostatic Neoplasms	28
Alzheimer Disease	9
Syndrome	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Choline C-11

Trials by Country

Map
Table

Trials by Country for Choline C-11
Location	Trials
United States	159
Korea, Republic of	12
France	9
Spain	9
United Kingdom	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Choline C-11
Location	Trials
California	18
Minnesota	10
Ohio	9
New Jersey	9
Texas	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Choline C-11

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Choline C-11
Clinical Trial Phase	Trials
Phase 4	27
Phase 3	31
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Choline C-11
Clinical Trial Phase	Trials
Completed	77
Unknown status	19
Not yet recruiting	17
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Choline C-11

Sponsor Name

Chart
Table

Sponsor Name for Choline C-11
Sponsor	Trials
National Cancer Institute (NCI)	17
Essentialis, Inc.	8
National Institutes of Health (NIH)	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Choline C-11
Sponsor	Trials
Other	181
Industry	49
NIH	32
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.